Literature DB >> 18657050

Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclasts.

Shengmei Feng1, Lianfu Deng, Wei Chen, Jianzhong Shao, Guoliang Xu, Yi-Ping Li.   

Abstract

Bone resorption relies on the extracellular acidification function of V-ATPase (vacuolar-type proton-translocating ATPase) proton pump(s) present in the plasma membrane of osteoclasts. The exact configuration of the osteoclast-specific ruffled border V-ATPases remains largely unknown. In the present study, we found that the V-ATPase subunit Atp6v1c1 (C1) is highly expressed in osteoclasts, whereas subunits Atp6v1c2a (C2a) and Atp6v1c2b (C2b) are not. The expression level of C1 is highly induced by RANKL [receptor activator for NF-kappaB (nuclear factor kappaB) ligand] during osteoclast differentiation; C1 interacts with Atp6v0a3 (a3) and is mainly localized on the ruffled border of activated osteoclasts. The results of the present study show for the first time that C1-silencing by lentivirus-mediated RNA interference severely impaired osteoclast acidification activity and bone resorption, whereas cell differentiation did not appear to be affected, which is similar to a3 silencing. The F-actin (filamentous actin) ring formation was severely defected in C1-depleted osteoclasts but not in a3-depleted and a3(-/-) osteoclasts. C1 co-localized with microtubules in the plasma membrane and its vicinity in mature osteoclasts. In addition, C1 co-localized with F-actin in the cytoplasm; however, the co-localization chiefly shifted to the cell periphery of mature osteoclasts. The present study demonstrates that Atp6v1c1 is an essential component of the osteoclast proton pump at the osteoclast ruffled border and that it may regulate F-actin ring formation in osteoclast activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18657050      PMCID: PMC2773039          DOI: 10.1042/BJ20081073

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification.

Authors:  Y P Li; W Chen; Y Liang; E Li; P Stashenko
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

2.  A band of F-actin containing podosomes is involved in bone resorption by osteoclasts.

Authors:  J Kanehisa; T Yamanaka; S Doi; K Turksen; J N Heersche; J E Aubin; H Takeuchi
Journal:  Bone       Date:  1990       Impact factor: 4.398

3.  Osteoclastic bone resorption by a polarized vacuolar proton pump.

Authors:  H C Blair; S L Teitelbaum; R Ghiselli; S Gluck
Journal:  Science       Date:  1989-08-25       Impact factor: 47.728

4.  The effects of stimulators of intracellular cyclic AMP on rat and chick osteoclasts in vitro: validation of a simplified light microscope assay of bone resorption.

Authors:  R J Murrills; D W Dempster
Journal:  Bone       Date:  1990       Impact factor: 4.398

Review 5.  Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology.

Authors:  Michael Forgac
Journal:  Nat Rev Mol Cell Biol       Date:  2007-11       Impact factor: 94.444

6.  Specificity of RGS10A as a key component in the RANKL signaling mechanism for osteoclast differentiation.

Authors:  Shuying Yang; Wei Chen; Philip Stashenko; Yi-Ping Li
Journal:  J Cell Sci       Date:  2007-10-01       Impact factor: 5.285

7.  RGS12 is essential for RANKL-evoked signaling for terminal differentiation of osteoclasts in vitro.

Authors:  Shuying Yang; Yi-Ping Li
Journal:  J Bone Miner Res       Date:  2007-01       Impact factor: 6.741

8.  Regulation of plasma membrane V-ATPase activity by dissociation of peripheral subunits.

Authors:  J P Sumner; J A Dow; F G Earley; U Klein; D Jäger; H Wieczorek
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

9.  RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulation.

Authors:  Shuying Yang; Yi-Ping Li
Journal:  Genes Dev       Date:  2007-07-12       Impact factor: 11.361

10.  Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border.

Authors:  R Baron; L Neff; D Louvard; P J Courtoy
Journal:  J Cell Biol       Date:  1985-12       Impact factor: 10.539

View more
  43 in total

1.  V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption.

Authors:  De-Qin Yang; Shengmei Feng; Wei Chen; Haibo Zhao; Christie Paulson; Yi-Ping Li
Journal:  J Bone Miner Res       Date:  2012-08       Impact factor: 6.741

2.  The silencing of cathepsin K used in gene therapy for periodontal disease reveals the role of cathepsin K in chronic infection and inflammation.

Authors:  W Chen; B Gao; L Hao; G Zhu; J Jules; M J MacDougall; J Wang; X Han; X Zhou; Y-P Li
Journal:  J Periodontal Res       Date:  2016-01-11       Impact factor: 4.419

3.  Odanacatib, A Cathepsin K-Specific Inhibitor, Inhibits Inflammation and Bone Loss Caused by Periodontal Diseases.

Authors:  Liang Hao; Jianwei Chen; Zheng Zhu; Michael S Reddy; John D Mountz; Wei Chen; Yi-Ping Li
Journal:  J Periodontol       Date:  2015-04-16       Impact factor: 6.993

Review 4.  Regulation of lysosome biogenesis and functions in osteoclasts.

Authors:  Julie Lacombe; Gérard Karsenty; Mathieu Ferron
Journal:  Cell Cycle       Date:  2013-08-05       Impact factor: 4.534

5.  C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1.

Authors:  Wei Chen; Guochun Zhu; Jun Tang; Hou-De Zhou; Yi-Ping Li
Journal:  J Pathol       Date:  2018-01-29       Impact factor: 7.996

6.  A RANKL-PKCβ-TFEB signaling cascade is necessary for lysosomal biogenesis in osteoclasts.

Authors:  Mathieu Ferron; Carmine Settembre; Junko Shimazu; Julie Lacombe; Shigeaki Kato; David J Rawlings; Andrea Ballabio; Gerard Karsenty
Journal:  Genes Dev       Date:  2013-04-18       Impact factor: 11.361

Review 7.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

8.  Inhibition of Rgs10 Expression Prevents Immune Cell Infiltration in Bacteria-induced Inflammatory Lesions and Osteoclast-mediated Bone Destruction.

Authors:  Sen Yang; Liang Hao; Matthew McConnell; Xuedong Zhou; Min Wang; Yan Zhang; John D Mountz; Michael Reddy; Paul D Eleazer; Yi-Ping Li; Wei Chen
Journal:  Bone Res       Date:  2013-09-01       Impact factor: 13.567

9.  A small molecule, odanacatib, inhibits inflammation and bone loss caused by endodontic disease.

Authors:  Liang Hao; Wei Chen; Matthew McConnell; Zheng Zhu; Sheng Li; Michael Reddy; Paul D Eleazer; Min Wang; Yi-Ping Li
Journal:  Infect Immun       Date:  2015-01-12       Impact factor: 3.441

10.  Monocyte-Specific Knockout of C/ebpα Results in Osteopetrosis Phenotype, Blocks Bone Loss in Ovariectomized Mice, and Reveals an Important Function of C/ebpα in Osteoclast Differentiation and Function.

Authors:  Wei Chen; Guochun Zhu; Joel Jules; Diep Nguyen; Yi-Ping Li
Journal:  J Bone Miner Res       Date:  2018-01-26       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.